Patient Costs Associated with Rosacea

Jackson G Turbeville; Hossein Alinia; Sara Moradi Tuchayi; Naeim Bahrami; Leah A Cardwell; Olabola Awosika; Irma Richardson; Karen E Huang; Steven R Feldman

doi:10.1016/j.det.2017.11.012

Patient Costs Associated with Rosacea

Dermatol Clin. 2018 Apr;36(2):167-170. doi: 10.1016/j.det.2017.11.012. Epub 2017 Dec 21.

Authors

Jackson G Turbeville¹, Hossein Alinia¹, Sara Moradi Tuchayi¹, Naeim Bahrami², Leah A Cardwell³, Olabola Awosika⁴, Irma Richardson¹, Karen E Huang¹, Steven R Feldman⁵

Affiliations

¹ Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA.
² Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA; Department of Biomedical Engineering, Virginia Polytechnic Institute and State University, Wake Forest University, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA.
³ Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA. Electronic address: lcardwell06@gmail.com.
⁴ Department of Dermatology, The George Washington Medical Faculty Associates, 2150 Pennsylvania Avenue Northwest, 2B-427, Washington, DC 20037, USA.
⁵ Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA; Department of Pathology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA; Department of Public Health Sciences, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA.

PMID: 29499800
DOI: 10.1016/j.det.2017.11.012

Abstract

The recalcitrance of rosacea to many treatment options may prompt patients to spend exorbitant amounts of money on unsubstantiated treatment regimens in an effort to achieve relief. The authors examine the relationship between disease severity and treatment cost across several demographic and socioeconomic strata. Familiarization of evidence-based clinical recommendations and consensus guidelines may equip physicians to educate patients about the most efficacious and cost-effective treatment options to assist patients in making cost-conscious decisions in the management of their rosacea.

Keywords: Erythematotelangiectatic; Health care cost; Papulopustular; Rosacea; Self-assessment; Severity.

MeSH terms

Complementary Therapies / economics
Female
Health Expenditures / statistics & numerical data*
Humans
Income*
Insurance, Health / economics*
Male
Rosacea / economics*
Rosacea / therapy
Severity of Illness Index